IGC Pharma, Inc.

Analysis for Ticker: IGC

IGC Pharma Inc is a clinical stage biotechnology company that uses artificial intelligence to develop treatments for Alzheimer's disease agitation and other neuropsychiatric disorders. The financial reality is a gruesome machine where the company burns nearly 4,8$ million in cash just to produce 1,2$ million in revenue from white-labeled hand sanitizers and hemp gummies. This is a business that functions like a child who spends 5$ on a lemonade stand just to make 1$ in sales and then expects the neighborhood to keep giving him money to cover the gap. By 03/2025, their cash was down to only 405.000$, and the only way they survive is by printing new shares of stock that dilute the ownership of everyone else until the original value is practically hollowed out.